Hap Trading, LLC Sage Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $385,280 - $531,860	-14,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$30.71 - $45.71 $3,071 - $4,571	100 Added 0.72%	14,000 $56,000
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $515,134 - $654,829	13,900 New	13,900 $38,000
Q2 2021 Aug 11, 2021	SELL	$54.88 - $79.29 $592,704 - $856,332	-10,800 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $5.22 Million - $7.15 Million	-73,900 Reduced 87.25%	10,800 $66,000
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $1.95 Million - $2.97 Million	-33,400 Reduced 28.28%	84,700 $12,000
Q3 2020 Nov 13, 2020	BUY	$41.13 - $62.45 $1.3 Million - $1.98 Million	31,700 Added 36.69%	118,100 $96,000
Q2 2020 Aug 10, 2020	BUY	$25.95 - $43.15 $2.24 Million - $3.73 Million	86,400 New	86,400 $240,000
Q1 2020 May 08, 2020	SELL	$26.15 - $77.24 $818,495 - $2.42 Million	-31,300 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$60.18 - $154.77 $5.04 Million - $13 Million	-83,700 Reduced 72.78%	31,300 $711,000
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $5.26 Million - $7.12 Million	37,500 Added 48.39%	115,000 $2.19 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $12.2 Million - $14.2 Million	77,500 New	77,500 $813,000
Q3 2018 Nov 09, 2018	SELL	$138.11 - $169.04 $1.8 Million - $2.2 Million	-13,000 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $2.22 Million - $2.78 Million	-15,800 Reduced 54.86%	13,000 $62,000
Q1 2018 May 11, 2018	SELL	$152.15 - $192.33 $36.1 Million - $45.6 Million	-237,100 Reduced 89.17%	28,800 $196,000
Q4 2017 Feb 09, 2018	BUY	$60.72 - $167.34 $16.1 Million - $44.5 Million	265,900	265,900 $89,000

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account